Results 1 to 10 of about 173,423,441 (192)

Clonal hematopoiesis of indeterminate potential and cardiovascular diseases: A review [PDF]

open access: yesIndian Heart Journal
Cardiovascular disease (CVD) is a major driver of mortality and declining health worldwide. Cardiovascular diseases (CVD) is the most common cause of morbidity and mortality globally. Although dyslipidemia, smoking, diabetes, hypertension and obesity are
Nagendra Boopathy Senguttuvan   +5 more
doaj   +4 more sources

Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View [PDF]

open access: yesJournal of the American Heart Association, 2023
Clonal hematopoiesis of indeterminate potential (CHIP) is a common bone marrow abnormality induced by age‐related DNA mutations, which give rise to proinflammatory immune cells. These immune cells exacerbate atherosclerotic cardiovascular disease and may
Job A J Verdonschot   +2 more
exaly   +4 more sources

CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2022
Hematopoietic stem cells (HSCs) ensure the coordinated and balanced production of all hematopoietic cell types throughout life. Aging is associated with a gradual decline of the self-renewal and regenerative potential of HSCs and with the development of
Ugo Testa   +2 more
doaj   +2 more sources

Risk factors of clonal hematopoiesis of indeterminate potential [PDF]

open access: yesClinical Medicine
Background: Accumulating evidence demonstrates associations between clonal hematopoiesis of indeterminate potential (CHIP) and increased risks of haematological and non-haematological health outcomes.
Qiaoxue Liu   +6 more
doaj   +2 more sources

Clonal Hematopoiesis of Indeterminate Potential: New Insights from Recent Studies

open access: yeshealthbook TIMES. Oncology Hematology, 2021
Clonal hematopoiesis of indeterminate potential (CHIP) is a condition characterized by accumulation of one or several somatic mutations in hematopoietic stem cells in the bone marrow.
Adrian Schmidt
doaj   +2 more sources

Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease: Gene-Specific Mechanisms and Therapeutic Implications [PDF]

open access: yesInternational Journal of General Medicine
Xuejiao Zhang,1 Hongguang Zhang,2 Jia Fu,2 Shuo Feng,2 Ying Wang31Department of Hematology, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, People’s Republic of China; 2Department of Cardiology, The First Hospital of China ...
Zhang X, Zhang H, Fu J, Feng S, Wang Y
doaj   +2 more sources

Clonal hematopoiesis of indeterminate potential and cardiovascular disease: mechanistic insights, clinical implications, and the dawn of precision cardio-hematology [PDF]

open access: yesFrontiers in Cardiovascular Medicine
Clonal hematopoiesis of indeterminate potential (CHIP) has substantially advanced our understanding of cardiovascular pathogenesis by demonstrating how somatic mutations in hematopoietic stem cells amplify the bone marrow–heart axis to accelerate ...
Hong Wu, Xinyi Meng, Long Li, Chao Zhang
doaj   +2 more sources

Clonal hematopoiesis of indeterminate potential and risk of autoimmune thyroid disease [PDF]

open access: yesBMC Medicine
Background Autoimmune thyroid disease (AITD) is the most common organ-specific autoimmune disease, often remaining asymptomatic until the thyroid is significantly affected. Clonal hematopoiesis of indeterminate potential (CHIP) has been reported to drive
Xue Zhang   +6 more
doaj   +2 more sources

Common in atherogenesis and carcinogenesis: clonal hematopoiesis

open access: yesРоссийский кардиологический журнал, 2023
Clonal hematopoiesis is a common age-dependent state accompanied by the expansion of mutant hematopoietic stem cells as a result of somatic mutations and is associated with a high risk of hematopoietic neoplasms and cardiovascular diseases.
A. A. Sleptsov   +2 more
doaj   +1 more source

A study of elective genome sequencing and pharmacogenetic testing in an unselected population

open access: yesMolecular Genetics & Genomic Medicine, 2021
Background Genome sequencing (GS) of individuals without a medical indication, known as elective GS, is now available at a number of centers around the United States.
Meagan Cochran   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy